Resistance to chemotherapy is mediated by genetic alterations that accumulate in the genome of the cancer cells. By assessing how experimentally controlled alterations in every individual gene of the genome modify the response to chemotherapy and integrating these results with available mutagenesis data of human cancers we can identify genes involved in chemoresistance.